Navigation Links
Top FDA Official Stephen P. Spielberg, MD, PhD, to Deliver Plenary Address at 2012 ISPE Annual Meeting
Date:9/12/2012

TAMPA, Fla., Sept. 12, 2012 /PRNewswire-USNewswire/ -- ISPE announced today that the FDA's Deputy Commissioner for Medical Products and Tobacco, Stephen P. Spielberg, MD, PhD, will deliver a plenary address at the 2012 ISPE Annual Meeting, taking place 11-14 November in San Francisco, Calif. USA. Spielberg's talk is titled "How the FDA is Advancing Regulatory Science through High Quality Collaboration," and will discuss how the FDA is addressing challenges and taking advantage of opportunities to advance regulatory science through collaborations with organizations like ISPE.

(Logo: http://photos.prnewswire.com/prnh/20120912/DC73253LOGO )

The plenary session will also feature an address by Murray Aitken, Executive Director, IMS Institute for Healthcare Informatics. Aitken's speech, titled "Top Priorities and Trends for the Pharmaceutical Industry," will deliver a global analysis of the industry supported by quantifiable data, as well as a forecast of top priorities and trends through 2016, including content that will be exclusive to ISPE's Annual Meeting.

The plenary session is part of a four-day conference program designed to give pharmaceutical professionals a better understanding of the industry's current technical and regulatory challenges and an opportunity to engage in open dialog to solve those challenges. Two special sessions will be of particular interest for those concerned with pharmaceutical quality, regulatory considerations or next steps for the industry:

  • Executive Series: Distinguished industry leaders will participate in a strategic discussion of key areas identified by technical leaders as critical to the future of the pharmaceutical industry. Attendees will hear "Confessions of a Counterfeiter," and other provocative discussion topics.
  • International Regulatory Summit: High-level regulators from North America, Europe, Asia and Latin America will discuss regional regulatory challenges and examine those challenges within the context of a global regulatory environment.

Watch this video to learn more about the 2012 ISPE Annual Meeting. Additional information, including complete education, speaker and registration details, is available at www.ISPE.org/2012AnnualMeeting.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading the scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; an Asia Pacific office in Singapore; and its newest office in Shanghai, China. Visit www.ISPE.org for additional Society news and information.

For more information contact:
Danielle Hould
ISPE Communications Manager
Tel: +1-813-960-2105, ext. 277
email: dhould@ispe.org
www.ISPE.org  


'/>"/>
SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rivalz Sports Group, Inc Sportstalk Station WRSO 810 AM Orlando Officially Takes Over And Goes Live With Sports Programming
2. seca - The Official Scale Provider For The 2012 Summer Olympics
3. Four-Time Triathlon World Champion Melanie McQuaid Selects Polar USA as Official Heart Rate Training Solution
4. The Medical Letter Launches More@MedLetter
5. The official blog of The Medical Letter
6. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
7. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
8. Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
9. Dr. David Brailer and Stephen Dubner Keynotes for NYeC 2012 Digital Health Conference
10. Philips continues to improve access to treatment for common cause of death in the U.S. with the delivery of its one-millionth AED
11. New Fluke intrinsically safe digital multimeter delivers extreme ruggedness for use in potentially explosive environments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
Breaking Medicine Technology:
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will ... set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is ... of Medicine. He also serves as Medical Director for the Bureau of Emergency Medical ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):